ロード中...
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular dysplasia resulting in visceral arteriovenous malformations and smaller mucocutaneous telangiectasia. Most patients experience recurrent nosebleeds and become anemic without iron supplementation. However, thousands may requir...
保存先:
| 出版年: | Orphanet J Rare Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714298/ https://ncbi.nlm.nih.gov/pubmed/31462308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-019-1179-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|